Skip to main content
AAPL+0.11%NVDA+1.04%MSFT+0.14%GOOGL+0.78%AMZN+0.26%TSM+6.33%SPCX+8.62%META+0.27%TSLA+0.40%AVGO+0.74%LLY-0.79%BRK-B-0.25%WMT-1.72%SKHY+2.78%JPM-0.84%V+0.01%MU+0.42%AMD+11.04%XOM+0.34%JNJ+1.43%MA-0.49%ASMLa+2.69%ABBV+1.07%0700.HK-0.26%1398.HK-0.16%COST-1.13%CVX-0.15%KO-0.06%PG-1.02%CSCO-1.95%0939.HK+0.14%UNH-0.40%ORCL+0.77%HD-1.85%BAC-0.68%GE+2.70%3988.HK+0.08%1816.HK+1.93%0857.HK-0.29%1288.HK+0.15%PM-1.80%NVS+0.38%0005.HK+0.61%INTC+7.71%HSBA.L-0.21%AZN-0.22%MS-0.55%SAPd-2.32%9988.HK-0.15%ORp-1.27%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURDKK0.00%EURUSD0.00%CHFJPY0.00%EURNZD0.00%EURJPY0.00%NZDMXN0.00%EURNOK0.00%GBPCHF0.00%EURCAD0.00%PLNJPY0.00%CHFNOK0.00%USDHKD0.00%USDZAR0.00%USDPLN0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%GBPCAD0.00%USDDKK0.00%GBPAUD0.00%GBPNZD0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CADCHF0.00%NZDJPY0.00%GBPZAR0.00%NZDCAD0.00%GBPSGD0.00%EURPLN0.00%W10.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.03%ETHUSD+28.71%USDTUSD+0.05%XRPUSD+24.39%SOLUSD+32.69%TRXUSDT+0.23%ZECUSDT+2.66%DOGEUSD+31.80%XMRUSDT-0.47%LINKUSD+1.72%BCHUSDT-4.06%XLMUSD+0.63%UNIUSD+3.52%LTCUSD+29.68%SUIUSD+3.58%HBARUSDT+0.82%TONUSD+55.81%TAOUSDT+5.08%AAVEUSD+2.38%DOTUSDT+0.20%ICPUSDT+1.93%ONDOUSDT+1.09%ARBUSDT+6.40%WLDUSDT-0.98%INJUSDT+1.48%JUPUSDT-1.14%ATOMUSDT-2.22%STXUSDT+2.64%TIAUSDT+8.32%PYTHUSDT+3.21%FETUSDT+2.70%SEIUSDT+3.36%IMXUSDT+4.92%OPUSDT+3.48%GRTUSDT+1.09%POLUSDT-0.34%WIFUSDT+0.74%IOTAUSDT-2.82%AXSUSDT+2.09%EOSUSDT-1.01%FARTCOINUSDT-0.05%DYDXUSDT+1.89%GALAUSDT+3.06%ORDIUSDT+1.39%RONINUSDT+1.33%NOTUSDT+2.44%AAPL+0.11%NVDA+1.04%MSFT+0.14%GOOGL+0.78%AMZN+0.26%TSM+6.33%SPCX+8.62%META+0.27%TSLA+0.40%AVGO+0.74%LLY-0.79%BRK-B-0.25%WMT-1.72%SKHY+2.78%JPM-0.84%V+0.01%MU+0.42%AMD+11.04%XOM+0.34%JNJ+1.43%MA-0.49%ASMLa+2.69%ABBV+1.07%0700.HK-0.26%1398.HK-0.16%COST-1.13%CVX-0.15%KO-0.06%PG-1.02%CSCO-1.95%0939.HK+0.14%UNH-0.40%ORCL+0.77%HD-1.85%BAC-0.68%GE+2.70%3988.HK+0.08%1816.HK+1.93%0857.HK-0.29%1288.HK+0.15%PM-1.80%NVS+0.38%0005.HK+0.61%INTC+7.71%HSBA.L-0.21%AZN-0.22%MS-0.55%SAPd-2.32%9988.HK-0.15%ORp-1.27%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%EURDKK0.00%EURUSD0.00%CHFJPY0.00%EURNZD0.00%EURJPY0.00%NZDMXN0.00%EURNOK0.00%GBPCHF0.00%EURCAD0.00%PLNJPY0.00%CHFNOK0.00%USDHKD0.00%USDZAR0.00%USDPLN0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%GBPCAD0.00%USDDKK0.00%GBPAUD0.00%GBPNZD0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CADCHF0.00%NZDJPY0.00%GBPZAR0.00%NZDCAD0.00%GBPSGD0.00%EURPLN0.00%W10.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.03%ETHUSD+28.71%USDTUSD+0.05%XRPUSD+24.39%SOLUSD+32.69%TRXUSDT+0.23%ZECUSDT+2.66%DOGEUSD+31.80%XMRUSDT-0.47%LINKUSD+1.72%BCHUSDT-4.06%XLMUSD+0.63%UNIUSD+3.52%LTCUSD+29.68%SUIUSD+3.58%HBARUSDT+0.82%TONUSD+55.81%TAOUSDT+5.08%AAVEUSD+2.38%DOTUSDT+0.20%ICPUSDT+1.93%ONDOUSDT+1.09%ARBUSDT+6.40%WLDUSDT-0.98%INJUSDT+1.48%JUPUSDT-1.14%ATOMUSDT-2.22%STXUSDT+2.64%TIAUSDT+8.32%PYTHUSDT+3.21%FETUSDT+2.70%SEIUSDT+3.36%IMXUSDT+4.92%OPUSDT+3.48%GRTUSDT+1.09%POLUSDT-0.34%WIFUSDT+0.74%IOTAUSDT-2.82%AXSUSDT+2.09%EOSUSDT-1.01%FARTCOINUSDT-0.05%DYDXUSDT+1.89%GALAUSDT+3.06%ORDIUSDT+1.39%RONINUSDT+1.33%NOTUSDT+2.44%
RE

ResMed Inc. (RMD)

NYSE • Healthcare

$235.3
-$4 (-1.7%)
Market closed

November 6, 2026 at 21:00 UTC

Open$234
Day Range$231.95 - $236.67
Avg. Volume (3M)1.4M
Market Cap$33B
P/E Ratio21.4
52 Week Range
$180.27$277.67
Next EarningsIn 82 daysJan 28, 2027

Interactive Chart

07:13:30 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$1.4B100%
Gross Profitminus cost of goods$870.5M62%
Operating Incomeminus R&D and overhead$452.9M32%
Net Incomeminus taxes and the rest$418.4M30%

In plain terms: out of every $100 in revenue, ResMed Inc. keeps $30 as net profit.

Fundamentals & Financials

Revenue (TTM)
$5.7B
Net Income (TTM)
$1.5B
EPS (TTM)
$10.99
ROA (TTM)
19.4%
Current Ratio
2.65
Dividend Yield
0.3%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.1%Q2 2026$2.86
+2.1%Q3 2026$2.95
+8.2%Q4 2026$2.91
Next

Jan 28

in 82 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +8.2%

ResMed beat expectations on both the top and bottom line in the first fiscal quarter of 2027, based on preliminary results reported October 29, 2026, with EPS of $2.91 topping the $2.69 estimate (+8.2%) and revenue of $1.415 billion topping the $1.394 billion estimate (+1.5%). Revenue rose ~6% to about $1.4 billion (up from $1.336 billion a year ago), supported by its Sleep and Respiratory Care and Software as a Service businesses, while profitability stayed elevated with gross margin at ~62% and operating margin at ~32%. Net income increased 20% year over year to roughly $418 million (up from $348.5 million), alongside the EPS increase from $2.55 a year ago. Cash generation in the quarter included operating cash flow of roughly $422 million, and the company returned capital through about $936 million of share repurchases and roughly $95 million in dividends. For the next period, consensus calls for EPS of $3.03 on revenue of $1.453 billion.

View full earnings history

About ResMed Inc.

ResMed Inc. (NYSE: RMD) makes and markets healthcare devices and connected digital solutions for sleep, respiratory, and out-of-hospital care. The company operates in the medical technology field and generated $5.1 billion in revenue in FY2025. Its business spans device hardware, software, and related services used across clinical and home-based care settings.

Name
ResMed Inc.
CEO
Michael J. Farrell
Industry
Healthcare
Year Founded
1989
Employees
11,370

Today's Snapshot

AI-generated

The day ended with RMD 1.7% lower at 235.31, while its sector was flat. ResMed started fiscal 2027 with $1 billion in revenue and higher earnings.

Trading Volume

Below 10d avg (1.7M)

1.3M

vs S&P 500 Today

Underperforming Market

-2.07%

Updated: November 6, 2026 at 21:08 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
RMD's indicators tilt toward a buy stance despite short-term weakness. The price near 235 sits below the 10/20-day averages but remains above the 50/100/200-day series, signaling recovery within a broader uptrend, and ADX in the high-20s shows a reasonably firm trend. Momentum is mixed—MACD is neutral and short-term momentum reads soft—while volatility is moderate with an ATR near 8. On-balance volume is not confirming strength, and the classic pivot around 239.7 sits above the current price as a nearby resistance. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$227.30 - $238.92
    Buy
  • RSI (14)48.27
    Neutral
  • Stochastic %K (14, 3, 3)49.39
    Neutral
  • MACD Level (12, 26)1.73
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.